Become a VIP for clearer skin. Sign up today.

Eczema, also known as atopic dermatitis or AD, is a chronic disease characterized by dry, itchy, inflamed skin with unpredictable flares. Eczema predominantly affects children, and the prevalence is only increasing. About 13% of children in the US have eczema, and it most commonly appears as dry, itchy patches on the face or neck, and in the folds of the elbows or knees.

Your healthcare provider can determine whether you or your child have eczema and what the best treatment option is.

VTAMA is a once-daily, steroid-free, prescription treatment for eczema that is approved by the FDA for adults and children as young as 2 years of age.

VTAMA can be used by anyone diagnosed with eczema who is 2 years of age or older who has been prescribed VTAMA.

Apply VTAMA once daily around the same time every day. You may choose the time of day that works best for you to apply VTAMA. For instance, you may feel it’s best to use it in the evening or before bedtime.

VTAMA is for use on the skin (topical use) only. VTAMA can even be used on affected sensitive skin areas, like your face and neck, armpits, chest/breasts, groin, and genitals. Do not use VTAMA in your eyes, mouth, or vagina.

Use VTAMA exactly as your healthcare provider tells you to use it.

Apply a thin layer of VTAMA only to your eczema one (1) time a day. Avoid applying VTAMA to unaffected areas of your skin.

Wash your hands after applying VTAMA, unless you are using it to treat eczema on your hands.

If someone else applies VTAMA for you, they should wash their hands after application.

Talk with your healthcare provider if you have questions about how to use VTAMA with moisturizers or cosmetic products.

In two primary studies investigating VTAMA, up to 46% of patients using VTAMA reached clear or almost clear skin* in 8 weeks compared to 18% using a cream with no active ingredient. ~82% of patients entered with or achieved clear or almost clear skin at least once while using VTAMA in a 48-week open-label clinical study.

In clinical studies, up to 56% of patients 12 years and older on VTAMA had significant itch reduction at 8 weeks compared to up to 34% of patients on cream with no active ingredient. Itch relief as early as Day 2 was reported in the pivotal studies by some patients.

Individual results may vary.

®Patients also achieved a ≥2-grade improvement from baseline in vIGA-AD^* score in 8 weeks.

Learn more about the VTAMA clinical trial results.

The most common side effects in patients with eczema treated with VTAMA were upper and lower respiratory tract infections, red raised bumps around the hair pores (folliculitis), headache, asthma, vomiting, ear infection, pain in extremity, and stomach-area (abdominal) pain.

VTAMA should be applied once daily. If you miss a dose, talk to your doctor.

If you are having trouble keeping track of when to apply VTAMA, consider setting a reminder to help.

Yes. VTAMA is a prescription medication. Talk to your healthcare provider about whether VTAMA is right for you.

Learn more about getting started with VTAMA.

MyVTAMA is the patient support program from Organon. It was created to give you support and assistance along your eczema treatment journey.

Organon is committed to making VTAMA accessible and affordable to commercially insured patients^† with eczema. With the MyVTAMA savings card, commercially insured patients may pay as little as $0 and no more than $35.

^†Eligibility required. This offer is invalid for patients whose prescription claims are eligible to be reimbursed, in whole or in part, by any governmental program.

Additional resources include the Patient Brochure and Doctor Discussion Guide, a questionnaire to help you prepare for appointments with a healthcare provider and get the most out of them.

VTAMA should be stored at room temperature, between 68°F to 77°F (20°C to 25°C).

It should not be frozen or exposed to excessive heat. Keep VTAMA and all medicines out of the reach of children.